FAQ/Help |
Calendar |
Search |
Today's Posts |
|
07-20-2017, 11:10 PM | #1 | ||
|
|||
Member
|
That's great Will, glad to hear that. Yes, Penn will be one of the trial locations. It's good that you told him of your interest now as there isn't going to be that many available slots at each location. 75 total for 25 sites.
|
||
Reply With Quote |
07-28-2017, 12:56 PM | #2 | ||
|
|||
Member
|
I wanted to share more information on the new Phase IIa clinical trial funded by our Foundation (MJFF) to test the safety and tolerability of nilotinib in Parkinson’s disease. The trial will investigate the potential of repurposing nilotinib (which many in the patient community know is an FDA-approved treatment for cancer of the white blood cells) in Parkinson’s disease.
You can read more details on the nilotinib trial on our blog and download our guide on what patients and families should know about repurposed therapies. -Debi |
||
Reply With Quote |
07-28-2017, 03:29 PM | #3 | ||
|
|||
Member
|
Quote:
Link to full press release: Michael J. Fox Foundation Announces Award to Drive Phase IIa Clinical Trial Investigating Potential Safety and Benefit of Nilotinib in Parkinson's Disease | Parkinson's Disease |
||
Reply With Quote |
08-01-2017, 07:14 AM | #4 | ||
|
|||
Member
|
The SoPD blog has just posted an article covering the two nilotinib phase II trials (i.e. Georgetown Uni. and MJFF et al.). The article includes a lot of background information, plus links to papers/articles containing further information.
Nilotinib: the other phase II trial | The Science of Parkinson's disease |
||
Reply With Quote |
"Thanks for this!" says: | Tupelo3 (08-02-2017) |
08-01-2017, 09:26 AM | #5 | ||
|
|||
Member
|
The Georgetown study will recruit 75 subjects and will be completed in July 2020.
|
||
Reply With Quote |
08-01-2017, 09:57 PM | #6 | ||
|
|||
Member
|
re: "will be completed in July 2020"
I noticed that too, and it's a similar end-date for the MJFF et al. trial. Maybe it's based on an expected slow recruitment process? All the more reason to get these announcements and articles spread around the PwP communities and forums. |
||
Reply With Quote |
08-02-2017, 09:41 AM | #7 | ||
|
|||
Member
|
Quote:
I do agree, we should all get the word out about the upcoming trial recruitment and cut the 6 month time down to one month. If that happens with both cohorts we can cut almost a year off of the study time. |
||
Reply With Quote |
08-02-2017, 09:30 AM | #8 | ||
|
|||
Member
|
Quote:
|
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Another double-blind, clinical study of Nilotinib for Parkinson's | Parkinson's Disease | |||